RESUMO
BACKGROUND: As the science of consultation-liaison psychiatry advances, the Academy of Consultation-Liaison Psychiatry's Guidelines and Evidence-Based Medicine Subcommittee reviews articles of interest to help academy members remain familiar with the latest in evidence-based practice. OBJECTIVE: We identify the 10 most important articles for clinical practice in consultation-liaison psychiatry from 2020 using the new Importance and Quality instrument for assessing scientific literature. METHODS: The subcommittee published annotated abstracts for 97 articles on the academy website in 2020. Reviewers then rated all articles on clinical importance to practice and quality of scholarship using the Importance and Quality instrument. We describe the 10 articles with the highest aggregate scores and analyze the reliability of Importance and Quality instrument. RESULTS: Twenty-four raters identified the top 10 scoring articles of 2020. These articles provide practical guidance on key areas of consultation-liaison psychiatry including management of COVID-19, lithium treatment for complex patients, medical risks among patients with severe mental illness, and substance use disorders in medical settings. The assessment instrument demonstrated good to excellent interrater reliability. CONCLUSION: These articles offer valuable guidance for consultation-liaison psychiatrists regardless of their practice area. Collaborative literature reviews with standardized assessments help clinicians deliver evidence-based care and foster a high standard of practice across the specialty.
Assuntos
Psiquiatria , Encaminhamento e Consulta , COVID-19/psicologia , Cannabis/efeitos adversos , Delírio/classificação , Encefalite , Medicina Baseada em Evidências , Humanos , Compostos de Lítio/efeitos adversos , Compostos de Lítio/uso terapêutico , Transtornos Mentais/complicações , Transtornos Mentais/mortalidade , Atenção Plena , Neoplasias/complicações , Neoplasias/mortalidade , Neoplasias/psicologia , Reprodutibilidade dos Testes , Infecções Sexualmente Transmissíveis/epidemiologiaRESUMO
BACKGROUND: The decreased life expectancy and care costs of mental disorders could be enormous. However, research that compares mortality and utilization concurrently across the major category of mental disorders is absent. This study investigated all-cause mortality and medical utilization among patients with and without mental disorders, with an emphasis on identifying the psychiatric category of high mortality and low medical utilization. METHODS: A total of 570,250 individuals identified from the 2002-2013 Taiwan National Health Insurance Reearch Database consistuted 285,125 psychiatric patients and 285,125 non-psychiatric peers through 1:1 dual propensity score matching (PSM). The expenditure survival ratio (ESR) was proposed to indicate potential utilization shortage. The category of mental disorders and 13 covariates were analyzed using the Cox proportional hazard model and general linear model (GLM) through SAS 9.4. RESULTS: PSM analyses indicated that mortality and total medical expenditures per capita were both significantly higher in psychiatric patients than those in non-psychiatric patients (all P <.0.0001). Patients with substance use disorders were reported having the youngest ages at diagnosis and at death, with the highest 25.64 of potential years of life loss (YPLL) and relevant 2904.89 of ESR. Adjusted Cox model and GLM results indicated that, compared with anxiety disorders, affective disorders and substance use disorders were significantly associated with higher mortality (HR = 1.246 and 1.064, respectively; all P < 0.05); schizophrenia was significantly associated with higher total medical expenditures per capita (P < 0.0001). Thirteen additional factors were significantly associated with mortality or utilization (all P < 0.05). CONCLUSION: Substance use disorders are the category of highest YPLL but notably in insufficient utilization. Health care utilization in patients with substance use disorders should be augmented timely after the diagnosis, especially toward home and community care. The factors related to mortality and utilization identified by this study merit clinical attention.
Assuntos
Transtornos Mentais/mortalidade , Aceitação pelo Paciente de Cuidados de Saúde , Adolescente , Adulto , Idoso , Bases de Dados Factuais , Feminino , Gastos em Saúde , Humanos , Masculino , Transtornos Mentais/economia , Pessoa de Meia-Idade , Programas Nacionais de Saúde , Aceitação pelo Paciente de Cuidados de Saúde/estatística & dados numéricos , Pontuação de Propensão , Modelos de Riscos Proporcionais , Estudos Retrospectivos , Esquizofrenia/economia , Transtornos Relacionados ao Uso de Substâncias , Taiwan/epidemiologia , Adulto JovemRESUMO
The risk of medical comorbidity in mental disorders with a particular focus on depressive syndromes Objectives: It has long been recognized that certain mental disorders, and in particular depressive syndromes, are associated with increased medical comorbidity. However, reliable data on the prevalence of comorbid medical diagnoses as well as the impact of these comorbidities on mortality are often rare and sometimes conflicting. Methods: A systematic literature review was conducted using PubMed and Google Scholar to provide a critical account of the current state of research on the comorbidities of medical and mental disorders, with a particular focus on depressive syndromes. Results: Among patients with mental disorders, all-cause mortality is about doubled as compared to the general population causing a significantly shortened life expectancy in the range of one to two decades. This excess mortality is primarily due to increased physical morbidity and mortality, and it cannot be excluded that, for patients with severe mental disorders, excess mortality has been increased over time. Depressive syndromes are often linked to a broad range of somatic symptoms and can be found in diseases, such as heart disease, stroke, diabetes mellitus, overweight/obesity, and asthma. Conclusion: Current studies provide ample evidence of close interactions between physical and mental health. Further developments in the field of psychosomatic medicine should take into consideration the health-related consequences of these interactions.
Assuntos
Causas de Morte , Comorbidade , Transtornos Mentais/mortalidade , Transtorno Depressivo/mortalidade , HumanosRESUMO
PURPOSE: Seattle-inspired rock and roll superstar Chris Cornell died by suicide in May 2017. In the northern hemisphere, May represents the peak of the widely replicated but still unexplained seasonal spring rhythm in suicide. Years earlier, Cornell had suffered openly from recurrent bouts of severe depression, and his early musical lyrics do indeed suggest an enduring sensitivity to the vicissitudes of depressed and suicidal states. Cornell's most famous song, Black Hole Sun, suggests a mixed mood state, the incidence of which also peaks in the spring. The present work explores Cornell's May suicide from a chronobiologic perspective. METHODS: Review of Cornell's lyrics and literature on suicide. RESULTS: Cornell's lyrics contain clear indicators of mixed depressive and seasonal imagery, highlighting 3 fundamental axioms of suicidology: (1) the yearly suicide rhythm peaks in May in the northern hemisphere, (2) mixed depressive states are particularly lethal, and (3) the suicide risk increases dramatically when recovering from depression and mood turns mixed. CONCLUSIONS: Cornell, in his life and music, left us with a novel and important hypothesis about the spring seasonality of suicide, namely, that the yearly suicide risk becomes maximal when winter turns to spring and there emerges a deadly mixed mood state under a May photoperiod, i.e., the suicide risk is maximal when a Black Hole Sun occurs in May. It is hoped that Cornell's legacy and sensitive hypothesis inspire research into the etiology and treatment of the spring seasonality of suicide risk and mixed mood states. LIMITATIONS: The Cornell hypothesis was formulated based in part on several speculative inferences regarding the course of his functioning just prior to his suicide.
Assuntos
Pessoas Famosas , Música , Estações do Ano , Suicídio , História do Século XXI , Humanos , Medicina nas Artes , Transtornos Mentais/mortalidade , Fotoperíodo , Estados UnidosRESUMO
Guideline commentary takes its place alongside Cochrane corner and Research unwrapped as part of our evidence series. The aim of Guideline commentary is to support you to critique and utilise newly published guidelines, enabling translation of appropriate recommendations to practice. The objective is to scrutinise recent guidelines to encourage an understanding of the key issues, recommendations and midwifery practice implications. This month, Hannah Rogers looks at the new MBRRACE report and is struck by the addition of mental health disorders as a cause of death. She also considers the proportion of women who suffer morbidity.
Assuntos
Morte Materna/estatística & dados numéricos , Transtornos Mentais/mortalidade , Transtornos Mentais/enfermagem , Tocologia/legislação & jurisprudência , Tocologia/normas , Guias de Prática Clínica como Assunto , Complicações na Gravidez/enfermagem , Feminino , Humanos , Mortalidade Materna , Gravidez , Reino UnidoRESUMO
OBJECTIVE: The objective was to examine prevalence of behavioral health disorders (BHDs) and co-occurring chronic medical conditions in a 3.4 million-member integrated health system. METHOD: Clinical databases identified 255,993 patients diagnosed with the most prevalent BHDs (cases): depression, anxiety, substance use, bipolar spectrum and attention deficit and hyperactivity (ADHD); non-BHD matched controls were created for all unique cases. Cases and controls were compared for prevalence of general medical conditions and specific chronic diseases and the Charlson Comorbidity Index (CMI). RESULTS: The five most common BHDs were depression (58%), anxiety (42%), substance use (16%), bipolar spectrum (6%) and ADHD (4%). Compared to controls, patients with depression (80.1% vs. 66.3%), anxiety (78.0% vs. 63.0%), substance use (74.0% vs. 59.9%), bipolar (75.3% vs. 60.7%) and ADHD (60.6% vs. 53.1%; all P<.001) had significantly higher prevalence of any medical comorbidities. Excluding ADHD, BHD cases had higher prevalence of selected chronic diseases and average CMI. CONCLUSIONS: BHDs in a largely commercially insured, employment-based health system are common and associated with a disproportionately higher burden of chronic medical disease and associated 10-year mortality risk rate. Given that co-occurrence of behavioral and medical conditions leads to elevated symptom burden, functional impairment, and healthcare costs, these findings highlight the importance of developing effective collaborative models of care in (nonpublic) employment-based health systems.
Assuntos
Doença Crônica/epidemiologia , Comorbidade , Efeitos Psicossociais da Doença , Transtornos Mentais/epidemiologia , Adulto , California/epidemiologia , Estudos de Casos e Controles , Doença Crônica/mortalidade , Prestação Integrada de Cuidados de Saúde/estatística & dados numéricos , Feminino , Humanos , Masculino , Transtornos Mentais/mortalidade , Pessoa de Meia-Idade , PrevalênciaRESUMO
Psychiatric disorders themselves--and not only the known psychotropic agents--lead to enhanced psychic and somatic morbidity, and not only as a so-called psychic reaction. Psychiatric disorders such as depression, anxiety disorders and schizophrenia are diseases with a high prevalence and incidence in most countries, and they are life-threatening because they induce--besides suicidality--also many somatic diseases such as coronary arte- riosclerotic syndrome and diabetes. As a result, they have an--often indirect--effect on mortality. In the future, studies should give greater attention to the underlying neurobiological mechanisms. True "psychosomatic medicine" consists of determining the combined biological effect of psychic and somatic factors and their interactions in greater detail.
Assuntos
Depressão/mortalidade , Depressão/psicologia , Transtornos Mentais/mortalidade , Transtornos Mentais/psicologia , Qualidade de Vida/psicologia , Estresse Psicológico/mortalidade , Estresse Psicológico/psicologia , Comorbidade , Alemanha , Humanos , Prevalência , Fatores de Risco , Taxa de SobrevidaRESUMO
BACKGROUND: two-thirds of older patients admitted as an emergency to a general hospital have co-existing mental health problems including delirium, dementia and depression. This study describes the outcomes of older adults with co-morbid mental health problems after an acute hospital admission. METHODS: a follow-up study of 250 patients aged over 70 admitted to 1 of 12 wards (geriatric, medical or orthopaedic) of an English acute general hospital with a co-morbid mental health problem and followed up at 180 days. RESULTS: twenty-seven per cent did not return to their original place of residence after the hospital admission. After 180 days 31% had died, 42% had been readmitted and 24% of community residents had moved to a care home. Only 31% survived without being readmitted or moving to a care home. However, 16% spent >170 of the 180 days at home. Significant predictors for poor outcomes were co-morbidity, nutrition, cognitive function, reduction in activities of daily living ability prior to admission, behavioural and psychiatric problems and depression. Only 42% of survivors recovered to their pre-acute illness level of function. Clinically significant behavioural and psychiatric symptoms were present at follow-up in 71% of survivors with baseline cognitive impairment, and new symptoms developed frequently in this group. CONCLUSIONS: the variable, but often adverse, outcomes in this group implies a wide range of health and social care needs. Community and acute services to meet these needs should be anticipated and provided for.
Assuntos
Envelhecimento/psicologia , Serviço Hospitalar de Emergência , Transtornos Mentais/psicologia , Saúde Mental , Admissão do Paciente , Sobreviventes/psicologia , Atividades Cotidianas , Fatores Etários , Idoso , Idoso de 80 Anos ou mais , Cognição , Comorbidade , Prestação Integrada de Cuidados de Saúde , Inglaterra/epidemiologia , Feminino , Instituição de Longa Permanência para Idosos , Hospitais Gerais , Humanos , Masculino , Transtornos Mentais/epidemiologia , Transtornos Mentais/mortalidade , Transtornos Mentais/terapia , Casas de Saúde , Alta do Paciente , Readmissão do Paciente , Prognóstico , Fatores de Risco , Fatores de TempoAssuntos
Prestação Integrada de Cuidados de Saúde/organização & administração , Transtornos Mentais/terapia , Serviços de Saúde Mental/organização & administração , Prestação Integrada de Cuidados de Saúde/normas , Hospitalização , Humanos , Expectativa de Vida , Transtornos Mentais/mortalidade , Serviços de Saúde Mental/normas , Minnesota/epidemiologia , Modelos Organizacionais , Avaliação das Necessidades , Ambulatório Hospitalar/organização & administração , Avaliação de Programas e Projetos de Saúde/métodos , Melhoria de QualidadeRESUMO
The aim of the study was to determine excess mortality associated with cannabis use disorders. Individuals entering treatment for cannabis use disorders were followed by use of Danish registers and standardized mortality ratios (SMRs) estimated. Predictors of different causes of death were determined. A total of 6445 individuals were included and 142 deaths recorded during 26,584 person-years of follow-up. Mortality was predicted by age, comorbid use of opioids, and lifetime injection drug use. For different causes of death the SMRs were: accidents: 8.2 (95% CI 6.3-10.5), suicide: 5.3 (95% CI 3.3-7.9), homicide/violence: 3.8 (95% CI 1.5-7.9), and natural causes: 2.8 (95% CI 2.0-3.7). Following exclusion of those with secondary use of opioids, cocaine, amphetamine, or injection drug use, SMRs for all causes of death remained significantly elevated except for homicide/violence. The study underlines the need to address mortality risk associated with cannabis use disorders.
Assuntos
Abuso de Maconha/mortalidade , Abuso de Maconha/reabilitação , Acidentes/estatística & dados numéricos , Adolescente , Adulto , Causas de Morte , Criança , Dinamarca/epidemiologia , Escolaridade , Emigrantes e Imigrantes , Família , Feminino , Previsões , Homicídio/estatística & dados numéricos , Humanos , Masculino , Transtornos Mentais/complicações , Transtornos Mentais/mortalidade , Transtornos Mentais/psicologia , Modelos de Riscos Proporcionais , Sistema de Registros , Fatores Socioeconômicos , Abuso de Substâncias por Via Intravenosa/complicações , Abuso de Substâncias por Via Intravenosa/mortalidade , Suicídio/estatística & dados numéricos , Violência/estatística & dados numéricos , Adulto JovemAssuntos
Prestação Integrada de Cuidados de Saúde/organização & administração , Transtornos Mentais/mortalidade , Suicídio/psicologia , Sistema de Vigilância de Fator de Risco Comportamental , Doença Crônica/mortalidade , Doença Crônica/psicologia , Comorbidade , Prestação Integrada de Cuidados de Saúde/normas , Feminino , Disparidades nos Níveis de Saúde , Humanos , Masculino , Transtornos Mentais/psicologia , Transtornos Mentais/terapia , Serviços de Saúde Mental/organização & administração , Pessoa de Meia-Idade , Atenção Primária à Saúde/organização & administração , Suicídio/estatística & dados numéricos , Estados Unidos/epidemiologiaRESUMO
UNLABELLED: Clinical holistic medicine (CHM) is short-term psychodynamic psychotherapy (STPP) complemented with bodywork and philosophical exercises, to be more efficient in treating patients with severe mental and physical illness. STPP has already been found superior to psychiatric treatment as usual (TAU) and thus able to compete with psychiatric standard treatment as the treatment of choice for all non-organic mental illnesses; we have found the addition of bodywork and philosophy of life to STPP to accelerate the process of existential healing and recovery (salutogenesis). In this paper we compare the side effects, suicidal risk, problems from implanted memory and implanted philosophy of CHM with psychopharmacological treatment. METHOD: Qualitative and quantitative comparative review. RESULTS: In all aspects of risks, harmfulness, and side effects, we have been considering, CHM was superior to the standard psychiatric treatment. The old principle of "first do no harm" is well respected by CHM, but not always by standard psychiatry. CHM seems to be able to heal the patient, while psychopharmacological drugs can turn the patient into a chronic, mentally ill patient for life. Based on the available data CHM seems another alternative to patients with mental illness. There seem to be no documentation at all for CHM being dangerous, harmful, having side effects of putting patients at risk for suicide. As CHM uses spontaneous regression there is no danger for the patient developing psychosis as, according to some experts, has been seen with earlier intensive psychodynamic methods. CHM is an efficient, safe and affordable cure for a broad range of mental illnesses.
Assuntos
Saúde Holística , Transtornos Mentais/mortalidade , Transtornos Mentais/terapia , Psicoterapia/estatística & dados numéricos , Medição de Risco/métodos , Adulto , Feminino , Humanos , Masculino , Prevalência , Fatores de Risco , Suicídio , Análise de Sobrevida , Taxa de Sobrevida , Estados UnidosRESUMO
BACKGROUND: The importance of cholesterol for physical and psychological well-being has been recognized for several decades. Changes in serum cholesterol levels may have a direct impact on mental performance, behavior, treatment response, survival and expected lifetime duration. OBJECTIVES: To examine the association between various mental disorders (schizophrenia, bipolar disorder, depression, generalized anxiety disorder, panic disorders, post-traumatic stress disorder and other mental disorders) and cholesterol levels, and to discuss the possible treatment implications. METHOD: A MEDLINE search, citing articles from 1966 onward, supplemented by a review of bibliographies, was conducted to identify relevant studies. Criteria used to identify studies included (1) English language, (2) published studies with original data in peer-reviewed journals. RESULTS: Clinical investigations of cholesterolemia in patients with major mental disorders have produced very conflicting results. Hypercholesterolemia has been reported in patients with schizophrenia, obsessive-compulsive disorders, panic disorder, generalized anxiety disorder, PTSD. Low cholesterol level has been reported in patients with major depression, dissociative disorder, antisocial personality disorder, borderline personality disorder. It seems that both high and low serum total cholesterol may be associated with a higher risk of the premature death. CONCLUSION: Our current knowledge on the relation between cholesterolemia and mental disorders is poor and controversial. No definite or reliable insight into a pathophysiological link between cholesterol levels and mental disorders, treatment response and mortality rate is available. The lipoprotein profile, rather than total cholesterol levels, seems to be important.
Assuntos
Colesterol/sangue , Saúde Holística , Transtornos Mentais/sangue , Encéfalo/fisiopatologia , Doenças Cardiovasculares/sangue , Doenças Cardiovasculares/mortalidade , Doenças Cardiovasculares/terapia , Causas de Morte , Humanos , Hipercolesterolemia/sangue , Transtornos Mentais/mortalidade , Transtornos Mentais/terapiaRESUMO
The Australian press played a vital part in bringing the events at Chelmsford Private Hospital to the attention of the general public, and in pressuring the New South Wales government to institute a Royal Commission into Deep Sleep Therapy. This paper describes the ways in which the press brought Chelmsford events onto the public agenda. It pays particular attention to aspects of the press coverage of the findings of the Royal Commission. The paper identifies the discourses concerning psychiatric care, the doctor-patient relationship and the role of the government in regulating the medical profession which were dominant in press accounts of Chelmsford. It is argued that while pre-existing stereotypes about mad psychiatrists and asylums were used to describe Chelmsford, more confronting ideas concerning the need for medical regulation and patient consumerism received press attention and therefore a public airing. The implications for psychiatric care in Australia are examined.